Zhou M[Auth] - Search Results

Year	Number of Results
1979	2
1980	2
1981	5
1982	3
1983	1
1984	2
1985	5
1986	5
1987	10
1988	9
1989	9
1990	18
1991	29
1992	25
1993	30
1994	29
1995	48
1996	29
1997	49
1998	52
1999	53
2000	62
2001	62
2002	73
2003	109
2004	123
2005	146
2006	203
2007	249
2008	288
2009	294
2010	368
2011	388
2012	461
2013	621
2014	688
2015	855
2016	893
2017	984
2018	1148
2019	1252
2020	1502
2021	1874
2022	217

1

Prevalence and Treatment of Diabetes in China, 2013-2018.

Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, Zhang X, Li C, Huang Z, Sun X, Wang L, Zhou M, Wu J, Wang Y. Wang L, et al. Among authors: zhou m. JAMA. 2021 Dec 28;326(24):2498-2506. doi: 10.1001/jama.2021.22208. JAMA. 2021. PMID: 34962526

2

A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy.

Fan F, Liu P, Bao R, Chen J, Zhou M, Mo Z, Ma Y, Liu H, Zhou Y, Cai X, Qian C, Liu X. Fan F, et al. Among authors: zhou m. Cancer Res. 2021 Dec 15;81(24):6233-6245. doi: 10.1158/0008-5472.CAN-21-1547. Epub 2021 Oct 28. Cancer Res. 2021. PMID: 34711611

3

Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].

Hua X, Liu Z, Zhou M, Tian Y, Zhao PP, Pan WH, Li CX, Huang XX, Liao ZX, Xian Q, Chen B, Hu Y, Leng L, Fang XW, Yu LN. Hua X, et al. Among authors: zhou m. EBioMedicine. 2021 Oct;72:103665. doi: 10.1016/j.ebiom.2021.103665. EBioMedicine. 2021. PMID: 34717838 Free PMC article. No abstract available.

4

Smart Nanogatekeepers for Tumor Theranostics.

Zhang X, Chen Y, He X, Zhang Y, Zhou M, Peng C, He Z, Gui S, Li Z. Zhang X, et al. Among authors: zhou m. Small. 2021 Nov;17(47):e2103712. doi: 10.1002/smll.202103712. Epub 2021 Oct 22. Small. 2021. PMID: 34677898 Review.

5

RNA m⁶A Modification in Immunocytes and DNA Repair: The Biological Functions and Prospects in Clinical Application.

Zhou M, Liu W, Zhang J, Sun N. Zhou M, et al. Front Cell Dev Biol. 2021 Dec 20;9:794754. doi: 10.3389/fcell.2021.794754. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34988083 Free PMC article. Review.

6

[Update on COVID-19 in 2021].

Zhou M, Qu JM. Zhou M, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2022 Jan 12;45(1):67-71. doi: 10.3760/cma.j.cn112147-20211028-00748. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 35000308 Chinese.

7

Cardiovascular Protective Effects of Plant Polysaccharides: A Review.

Dong X, Zhou M, Li Y, Li Y, Ji H, Hu Q. Dong X, et al. Among authors: zhou m. Front Pharmacol. 2021 Nov 18;12:783641. doi: 10.3389/fphar.2021.783641. eCollection 2021. Front Pharmacol. 2021. PMID: 34867415 Free PMC article. Review.

8

Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities.

Zhang PN, Zhou MQ, Guo J, Zheng HJ, Tang J, Zhang C, Liu YN, Liu WJ, Wang YX. Zhang PN, et al. Among authors: zhou mq. J Diabetes Res. 2021 Dec 9;2021:1010268. doi: 10.1155/2021/1010268. eCollection 2021. J Diabetes Res. 2021. PMID: 34926696 Free PMC article. Review.

9

The role of alternative splicing in human cancer progression.

Ouyang J, Zhang Y, Xiong F, Zhang S, Gong Z, Yan Q, He Y, Wei F, Zhang W, Zhou M, Xiang B, Wang F, Li X, Li Y, Li G, Zeng Z, Guo C, Xiong W. Ouyang J, et al. Among authors: zhou m. Am J Cancer Res. 2021 Oct 15;11(10):4642-4667. eCollection 2021. Am J Cancer Res. 2021. PMID: 34765285 Free PMC article. Review.

10

Peptidomimetic-based antibody surrogate for HER2.

Zheng M, Li C, Zhou M, Jia R, She F, Wei L, Cheng F, Li Q, Cai J, Wang Y. Zheng M, et al. Among authors: zhou m. Acta Pharm Sin B. 2021 Sep;11(9):2645-2654. doi: 10.1016/j.apsb.2021.04.016. Epub 2021 May 1. Acta Pharm Sin B. 2021. PMID: 34589386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results